All treatments
Treatment
Empagliflozin 10 mg clinical trials
3 indexed studies · 3 currently recruiting
- Not yet recruitingPHASE3
SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure
This study is testing if a drug called empagliflozin can help adults with Fontan Circulatory Failure (FCF) feel better and improve their daily lives. FCF is a heart condition some people are born with.
For: Congenital Heart DiseaseCanada - Not yet recruitingPHASE3
Trial to Assess the Efficacy of EMPAgliflozin and Personalized Dietary Counseling for Kidney STONE Prevention
This study looks at new ways to stop kidney stones from coming back. It tests a medication called empagliflozin and special diet advice to see if they can help people who get calcium kidney stones often.
For: Kidney Stone · Nephrolithiasis · Dietary ExposureFrance · Germany · Italy - RecruitingPHASE2, PHASE3
EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source
This study investigates if empagliflozin, a diabetes drug, can prevent heart rhythm problems (atrial fibrillation) in people who've had a stroke with no clear cause. It uses advanced scans and monitoring to see how the drug affects the heart's upper chambers.
For: Embolic Stroke of Undetermined Source · Atrial Fibrillation New OnsetUnited Kingdom